Lipid profile in Tunisian patients with rheumatoid arthritis (Q39054846)

8 September 2017

title

Lipid profile in Tunisian patients with rheumatoid arthritis (English)

1 reference

8 September 2017

0 references

Saoussen Hassen Zrour

1

1 reference

8 September 2017

Fadoua Hassine Neffeti

2

1 reference

8 September 2017

Nabil Sakly

3

1 reference

8 September 2017

Mahbouba Jguirim

4

1 reference

8 September 2017

Wided Korbaa

5

1 reference

8 September 2017

Mohamed Younes

6

1 reference

8 September 2017

Ismail Bejia

7

1 reference

8 September 2017

Mongi Touzi

8

1 reference

8 September 2017

Najjar Mohamed Fadel

9

1 reference

8 September 2017

Naceur Bergaoui

10

1 reference

8 September 2017

publication date

27 April 2011

1 reference

8 September 2017

published in

Clinical Rheumatology

1 reference

8 September 2017

volume

30

1 reference

8 September 2017

issue

10

1 reference

8 September 2017

page(s)

1325-1331

1 reference

Atherosclerosis and rheumatoid arthritis

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Accelerated atherosclerosis in autoimmune rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Rheumatoid arthritis: model of systemic inflammation driving atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

The importance of non-HDL cholesterol reporting in lipid management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Cardiovascular risk factors in women with and without rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Predicting mortality in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Role of inflammation in atherosclerosis associated with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Atherogenic serum lipid profile is an independent predictor for gouty flares in patients with gouty arthropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Changes in plasma free fatty acid concentrations in rheumatoid arthritis patients during fasting and their effects upon T-lymphocyte proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Carotid intima-media thickness and endothelial function: useful surrogate markers for establishing cardiovascular risk in patients with inflammatory rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Inflammation, carotid intima-media thickness and atherosclerosis in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1755-9

Lipid profiles in untreated patients with rheumatoid arthritis

21 January 2018

1 reference

12 December 2020

Association of mortality with disease severity in rheumatoid arthritis, independent of comorbidity

1 reference

12 December 2020

The Disease Activity Score and the EULAR response criteria

1 reference

12 December 2020

Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized study

1 reference

12 December 2020

Therapeutic criteria in rheumatoid arthritis

1 reference

12 December 2020

When is a patient with rheumatoid arthritis at risk for cardiovascular disease?

1 reference

12 December 2020

Atherogenic lipid profiles and its management in patients with rheumatoid arthritis

1 reference

12 December 2020

Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis

1 reference

12 December 2020

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

1 reference

12 December 2020

Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis

1 reference

12 December 2020

Which are the determinants of dyslipidemia in rheumatoid arthritis and does socioeconomic status matter in this context?

1 reference

12 December 2020

Influence of dietary habits, age and gender on plasma fatty acids levels in a population of healthy Tunisian subjects

1 reference

12 December 2020

10.1007/S10067-011-1755-9

Identifiers

DOI

1 reference

8 September 2017

1 reference